Dashboard
Manage Tickers

HIMS


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hims--hers-health-inc-files-for-mixed-shelf-offering-size-not-disclosed
Hims & Hers Health Inc. Files For Mixed Sh...
09/09/2024 20:04:25

- SEC Filing

battle-over-compounded-weight-loss-medications---sustainability-and-regulation
Battle Over Compounded Weight-Loss Medicat...
09/05/2024 16:47:47

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

hearing-blog-post-capitol-forum-reports-former-pharmacists-raise-concerns-over-patient-safety-and-compounding-practices-at-hims--hers-health
Hearing Blog Post; Capitol Forum Reports F...
08/29/2024 19:09:36

why-hims--hers-health-stock-is-falling
Why Hims & Hers Health Stock Is Falling
08/27/2024 14:54:44

Eli Lilly's launch of the competitively priced Zepbound has triggered a 4.9% drop in Hims & Hers' stock. This has r...

american-woodmark-reports-downbeat-results-joins-snowflake-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
American Woodmark Reports Downbeat Results...
08/27/2024 12:12:10

hims--hers-health-sees-major-growth-opportunity-in-booming-weight-loss-market-says-analyst
Hims & Hers Health Sees Major Growth Oppor...
08/22/2024 18:26:20

Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive...

the-latest-analyst-ratings-for-hims--hers-health
The Latest Analyst Ratings For Hims & Hers...
08/22/2024 14:00:22

hims--hers-health-shares-are-trading-higher-after-needham-initiated-coverage-on-the-stock-with-a-buy-rating-and-announced-a-price-target-of-24
Hims & Hers Health shares are trading high...
08/22/2024 12:55:24

needham-initiates-coverage-on-hims--hers-health-with-buy-rating-announces-price-target-of-24
Needham Initiates Coverage On Hims & Hers ...
08/22/2024 11:01:36

Needham analyst Ryan MacDonald initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Pric...

looking-into-hims--hers-healths-recent-short-interest
Looking Into Hims & Hers Health's Recent S...
08/19/2024 19:15:18

telehealth-firm-hims--hers-health-rides-high-on-demand-for-copycat-weight-loss-drugs-amid-supply-shortages
Telehealth Firm Hims & Hers Health Rides H...
08/19/2024 13:24:02

Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss ...

hims--hers-health-unusual-options-activity-for-august-13
Hims & Hers Health Unusual Options Activit...
08/13/2024 15:47:11

deutsche-bank-maintains-hold-on-hims--hers-health-raises-price-target-to-23
Deutsche Bank Maintains Hold on Hims & Her...
08/07/2024 17:31:07

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from ...

analyst-expectations-for-hims--hers-healths-future
Analyst Expectations For Hims & Hers Healt...
08/06/2024 20:01:49

piper-sandler-reiterates-neutral-on-hims--hers-health-maintains-18-price-target
Piper Sandler Reiterates Neutral on Hims &...
08/06/2024 17:51:38

Piper Sandler analyst Korinne Wolfmeyer reiterates Hims & Hers Health (NYSE:HIMS) with a Neutral and maintains $18 price...

Core News & Articles
Top 10 Trending Stocks On WallStreetBets A...
08/06/2024 13:19:31

NVDAWAYINTCAAPLMADELOTHIMSPLTRQQQTSLAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment  NVDAWAYINTCA...

hims--hers-health-reports-better-than-expected-q2-results-details
Hims & Hers Health Reports Better-Than-Exp...
08/05/2024 20:26:43

Hims & Hers Health reported its second-quarter financial results Monday. Here's a look at the details from the report.

hims--hers-health-expects-q3-revenue-of-375m---380m-est-32389m
Hims & Hers Health Expects Q3 Revenue Of $...
08/05/2024 20:21:44

Adjusted EBITDA of $35 million to $40 million, reflecting an Adjusted EBITDA margin of 9% to 11%.

hims--hers-health-raises-fy24-revenue-guidance-from-120b---123b-to-137b---140b-est-1244b
Hims & Hers Health Raises FY24 Revenue Gui...
08/05/2024 20:20:15

Raises full year 2024 Adjusted EBITDA guidance to a range of $140 million to $155 million

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION